Treatment retention, return to use, and recovery support following COVID-19 relaxation of methadone take-home dosing in two rural opioid treatment programs: A mixed methods analysis

Original research

par

Hoffman, Kim A. et al

Date de publication

2022

Géographie

USA

Langue de la ressource

English

Texte disponible en version intégrale

Non

Open Access / OK to Reproduce

Non

Évalué par des pairs

Yes

L’objectif

We assessed the effects of COVID-19-related changes on take-home methadone dosing in two opioid treatment programs serving five rural Oregon counties.

Constatations/points à retenir

Take-home methadone dose relaxations were associated with increased methadone take-home doses, improved retention, and decreased UDT opioid positive results among clinically stable patients. Qualitative findings suggest that fewer take-home restrictions are feasible and desirable and do not pose safety or public health harms.

La conception ou méthodologie de recherche

Mixed methods

doi.org

Mots clés

Policy/Regulatory

About PWUD

Outcomes

Illegal drugs

Substitution/OAT

Carries/take-home doses